TABLE 2.
Susceptibilities of antimicrobial agents for the donor and the transconjugant strains
| Strain | MIC (mg/liter)a
|
|||||
|---|---|---|---|---|---|---|
| KAN | TE | SuM | STR | FCC | RIF | |
| E. coli 03/16 | >256 | >256 | >256 | 128 | 16 | 2 |
| Transconjugant | 128 | 128 | 128 | 128 | 16 | >256 |
| E. coli 04/18 | >256 | >256 | >256 | >256 | 32 | 4 |
| Transconjugant | >256 | >256 | >256 | 64 | 16 | >256 |
| Salmonella serovar Enteritidis 03/22 | 128 | 128 | >256 | >256 | 32 | <0.5 |
| Transconjugant | 128 | 64 | >256 | >256 | 16 | 128 |
| K. pneumoniae 04/22 | >256 | 64 | >256 | >256 | 32 | <0.5 |
| Transconjugant | 128 | 32 | 128 | >256 | 16 | 128 |
a
KAN, kanamycin; TE, tetracycline; SuM, sulfamethoxazole; STR, streptomycin; FCC, florfenicol; RIF, rifampin.